This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Pharma Mar, S.a.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Gema Santamaría Núñez: Innovator in Cancer Treatment
Introduction
Gema Santamaría Núñez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of oncology through her innovative research and development of cancer therapies. Her work focuses on combining various anticancer agents to enhance treatment efficacy.
Latest Patents
Gema holds a patent for a groundbreaking invention titled "Combination therapy with an antitumor alkaloid." This patent involves the combination of PM01183 with several anticancer drugs, including antitumor platinum coordination complexes, antimetabolites, and various inhibitors. The invention aims to improve cancer treatment outcomes by utilizing these combinations effectively.
Career Highlights
Gema is associated with Pharma Mar, S.A., a leading biopharmaceutical company specializing in the development of innovative therapies for cancer treatment. Her work at Pharma Mar has positioned her as a key player in the advancement of cancer therapies.
Collaborations
Gema collaborates with notable colleagues, including Victoria Moneo Ocaña and Luis Francisco García Fernández. These partnerships enhance her research efforts and contribute to the development of effective cancer treatments.
Conclusion
Gema Santamaría Núñez is a trailblazer in the field of cancer therapy, with her innovative patent and collaborative efforts paving the way for improved treatment options. Her contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile